BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1173 related articles for article (PubMed ID: 24318541)

  • 1. Incidence, risk factors, and implemented prophylaxis of varicella zoster virus infection, including complicated varicella zoster virus and herpes simplex virus infections, in lenalidomide-treated multiple myeloma patients.
    König C; Kleber M; Reinhardt H; Knop S; Wäsch R; Engelhardt M
    Ann Hematol; 2014 Mar; 93(3):479-84. PubMed ID: 24318541
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Varicella-zoster virus-specific cell-mediated immunity and herpes zoster development in multiple myeloma patients receiving bortezomib- or thalidomide-based chemotherapy.
    Kim JW; Min CK; Mun YC; Park Y; Kim BS; Nam SH; Koh Y; Kwon JH; Choe PG; Park WB; Kim I
    J Clin Virol; 2015 Dec; 73():64-69. PubMed ID: 26546878
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Varicella-zoster virus prophylaxis with low-dose acyclovir in patients with multiple myeloma treated with bortezomib.
    Pour L; Adam Z; Buresova L; Krejci M; Krivanova A; Sandecka V; Zahradova L; Buchler T; Vorlicek J; Hajek R
    Clin Lymphoma Myeloma; 2009 Apr; 9(2):151-3. PubMed ID: 19406726
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acyclovir prophylaxis against varicella zoster virus reactivation in multiple myeloma patients treated with bortezomib-based therapies: a retrospective analysis of 100 patients.
    Swaika A; Paulus A; Miller KC; Sher T; Almyroudis NG; Ball D; Wood M; Masood A; Lee K; Chanan-Khan AA
    J Support Oncol; 2012; 10(4):155-9. PubMed ID: 22222250
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factors influencing varicella zoster virus infection after allogeneic peripheral blood stem cell transplantation: low-dose acyclovir prophylaxis and pre-transplant diagnosis of lymphoproliferative disorders.
    Kim DH; Messner H; Minden M; Gupta V; Kuruvilla J; Wright J; Lipton J
    Transpl Infect Dis; 2008 Apr; 10(2):90-8. PubMed ID: 17605742
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Daily 500 mg valacyclovir is effective for prevention of Varicella zoster virus reactivation in patients with multiple myeloma treated with bortezomib.
    Fukushima T; Sato T; Nakamura T; Iwao H; Nakajima A; Miki M; Sakai T; Kawanami T; Sawaki T; Fujita Y; Tanaka M; Masaki Y; Okazaki T; Nakajima H; Motoo Y; Umehara H
    Anticancer Res; 2012 Dec; 32(12):5437-40. PubMed ID: 23225448
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decrease in CD4+ T-cell counts in patients with multiple myeloma treated with bortezomib.
    Heider U; Rademacher J; Kaiser M; Kleeberg L; von Metzler I; Sezer O
    Clin Lymphoma Myeloma Leuk; 2010 Apr; 10(2):134-7. PubMed ID: 20371447
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acyclovir to prevent reactivation of varicella zoster virus (herpes zoster) in multiple myeloma patients receiving bortezomib therapy.
    Vickrey E; Allen S; Mehta J; Singhal S
    Cancer; 2009 Jan; 115(1):229-32. PubMed ID: 19090004
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of brincidofovir as prophylaxis against HSV and VZV in hematopoietic cell transplant recipients.
    Lee YJ; Neofytos D; Kim SJ; Cheteyan L; Huang YT; Papadopoulos EB; Jakubowski AA; Papanicolaou GA
    Transpl Infect Dis; 2018 Dec; 20(6):e12977. PubMed ID: 30120866
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disseminated herpes simplex virus and varicella zoster virus coinfection in a patient taking thalidomide for relapsed multiple myeloma.
    Curley MJ; Hussein SA; Hassoun PM
    J Clin Microbiol; 2002 Jun; 40(6):2302-4. PubMed ID: 12037117
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Herpes virus infections in immunosuppressed patients. Herpes simplex and varicella zoster virus: prevention and therapy].
    Mertens T
    Fortschr Med; 1989 Aug; 107(25):537-40. PubMed ID: 2553562
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Varicella zoster infection after bone marrow transplantation: incidence, risk factors and complications.
    Han CS; Miller W; Haake R; Weisdorf D
    Bone Marrow Transplant; 1994 Mar; 13(3):277-83. PubMed ID: 8199570
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prophylactic antivirals may be helpful in prevention of varicella-zoster virus reactivation in myeloma, but are they safe?
    Dasanu CA; Alexandrescu DT
    J Oncol Pharm Pract; 2010 Dec; 16(4):266-8. PubMed ID: 19965947
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Analysis of varicella zoster virus infection following allogeneic stem cell transplants].
    Doki N; Hoshino T; Irisawa H; Sakura T; Miyawaki S
    Rinsho Ketsueki; 2004 Oct; 45(10):1090-4. PubMed ID: 15553042
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Varicella-zoster infection after allogeneic bone marrow transplantation: incidence, risk factors and prevention with low-dose aciclovir and ganciclovir.
    Steer CB; Szer J; Sasadeusz J; Matthews JP; Beresford JA; Grigg A
    Bone Marrow Transplant; 2000 Mar; 25(6):657-64. PubMed ID: 10734301
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of acyclovir and prednisolone on the serological response in herpes zoster.
    Bates CJ; Kudesia G; McKendrick MW
    J Med Virol; 1996 Nov; 50(3):244-8. PubMed ID: 8923289
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of low-dose aciclovir on reactivation of varicella zoster virus after allogeneic haemopoietic stem cell transplantation.
    Thomson KJ; Hart DP; Banerjee L; Ward KN; Peggs KS; Mackinnon S
    Bone Marrow Transplant; 2005 Jun; 35(11):1065-9. PubMed ID: 15806119
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polish consensus guidelines on the use of acyclovir in the treatment and prevention of VZV and HSV infections.
    Szenborn L; Kraszewska-Głomba B; Jackowska T; Duszczyk E; Majda-Stanisławska E; Marczyńska M; Ołdak E; Pawłowska M; Służewski W; Wysocki J; Stryczyńska-Kazubska J; Kuchar E
    J Infect Chemother; 2016 Feb; 22(2):65-71. PubMed ID: 26643900
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of varicella-zoster virus DNA in 414 human trigeminal ganglia from cadavers by the polymerase chain reaction: a comparison of the detection rate of varicella-zoster virus and herpes simplex virus type 1.
    Inoue H; Motani-Saitoh H; Sakurada K; Ikegaya H; Yajima D; Hayakawa M; Sato Y; Otsuka K; Kobayashi K; Nagasawa S; Iwase H
    J Med Virol; 2010 Feb; 82(2):345-9. PubMed ID: 20029810
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiviral resistance in herpes simplex virus and varicella-zoster virus infections: diagnosis and management.
    Piret J; Boivin G
    Curr Opin Infect Dis; 2016 Dec; 29(6):654-662. PubMed ID: 27306564
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 59.